What is the optimal treatment for biphenotypic acute leukemia?

Haematologica

Volumn 94, Issue 12, 2009, Pages 1778-1780

  Zheng, Changcheng ^a   Wu, Jingsheng ^a   Liu, Xin ^a   Ding, Kaiyang ^a   Cai, Xiaoyan ^a   Zhu, Weibo ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Biphenotypic leukemia; Immunophenotype; Treatment protocol

Indexed keywords

ASPARAGINASE; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; HOMOHARRINGTONINE; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; B LYMPHOCYTE; BLAST CELL; BONE MARROW CELL; BRAIN METASTASIS; CANCER REGRESSION; CELL POPULATION; CHINA; CLINICAL ARTICLE; CONTINUOUS INFUSION; DEATH; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNOPHENOTYPING; INCIDENCE; KARYOTYPE; LETTER; LEUKEMIA RELAPSE; LEUKOCYTE COUNT; MALE; MULTIPLE CYCLE TREATMENT; MYELOBLAST; OVERALL SURVIVAL; PROGNOSIS; STEM CELL; T LYMPHOCYTE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; LEUKEMIA, BIPHENOTYPIC, ACUTE; PEROXIDASE; PROGNOSIS; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 73149084179     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.014829     Document Type: Letter

References (7)

1. Xu XQ, Wang JM, Lü SQ, Chen L, Yang JM, Zhang WP, et al. Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population. Haematologica 2009; 94:919-27.
2. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995;9:1783-6.
3. Zaki SR, Austin GE, Swan D, Srinivasan A, Ragab AH, Chan WC, et al. Human myeloperoxidase gene expression in acute leukemia. Blood 1989;74:2096-102.
4. Lubbert M, Oster W, Ludwig WD, Ganser A, Mertelsmann R, Herrmann F, et al. A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias. Blood 1992;80:2066-73.
5. Matsuo T, Kuriyama K, Miyazaki Y, Yoshida S, Tomonaga M, Emi N, et al. The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype. Leukemia 2003;17: 1538-43.
6. Rubnitz JE, Onciu M, Pounds S, Shurtleff S, Cao X, Raimondi SC, et al. Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital. Blood 2009;113:5083- 9.
7. Weir EG, Ali Ansari-Lari M, Batista DA, Griffin CA, Fuller S, Smith BD, et al. Acute bilineal leukemia: a rare disease with poor outcome. Leukemia 2007;21:2264-70.